BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|January 1, 2007
- Volume 0 0
DRUG COMPANY OFFERS SAVINGS FOR PART D ENROLLEES
Advertisement
AstraZeneca recently launched AZ Medicine &Me for Medicare Part D beneficiaries who may havedifficulty affording their medications. Individualswho qualify and enroll will be able to visit their participatinglocal pharmacy and receive immediatesavings on AstraZeneca products.
To qualify for the program, an individual mustmeet the following criteria:
- Enroll in Medicare Part D
- Have an annual individual income at or below$30,000 (or an annual income at or below$40,000 per couple)
- Take AstraZeneca medications
- Have spent at least 3% of annual householdincome on prescription drugs during the calendaryear
Individuals who qualify for the program will pay nomore than $25 for a typical 30-day supply of theirAstraZeneca medicine and will receive the assistanceat the pharmacy counter immediately.
Articles in this issue
almost 20 years ago
Preventing Rasagiline Drug Interactionsalmost 20 years ago
nacds SPEAKS OUT: Specialty Pharmaceuticals on the Risealmost 20 years ago
Strategies for Coping with Alzheimer's Diseasealmost 20 years ago
Captive at the Counter: When Robbers Take Hostages—Part 1almost 20 years ago
A Third Category? Medicines Go Behind the Counteralmost 20 years ago
Avoiding Common Dispensing Errorsalmost 20 years ago
Pharm School Receives Grant to Help with Part Dalmost 20 years ago
compounding HOTLINEalmost 20 years ago
The Pharmacist's Role in the Management of Alzheimer's Diseasealmost 20 years ago
A Challenging Path to a PharmD DegreeAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5